5-HT1A, 5-HT2A, and 5-HT2C receptor mRNA modulation by antidepressant treatment in the chronic mild stress model of depression: Sex differences exposed

Neuroscience

Volumn 210, Issue , 2012, Pages 152-167

  Pitychoutis, P M ^a,c   Dalla, C ^a   Sideris, A C ^a   Tsonis, P A ^b   Papadopoulou Daifoti, Z ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF DAYTON   (United States)

^c INSERM   (France)

Author keywords

Clomipramine; Females; Gender; Hippocampus; Orbitofrontal cortex; Serotonergic system

Indexed keywords

CLOMIPRAMINE; MESSENGER RNA; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC MILD STRESS; CHRONIC STRESS; CONTROLLED STUDY; DENTATE HILUS; DEPRESSION; DISEASE MODEL; FEMALE; GENE EXPRESSION; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; ORBITAL CORTEX; PRIORITY JOURNAL; RAT; SEX DIFFERENCE;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BRAIN; CLOMIPRAMINE; DEPRESSION; DISEASE MODELS, ANIMAL; FEMALE; IN SITU HYBRIDIZATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RNA, MESSENGER; SEX CHARACTERISTICS; STRESS, PSYCHOLOGICAL;

EID: 84861194093     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.03.003     Document Type: Article

References (122)

1. Albert P.R., Zhou Q.Y., Van Tol H.H., Bunzow J.R., Civelli O. Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene. J Biol Chem 1990, 265:5825-5832.
2. Anderson I.M., Juhasz G., Thomas E., Downey D., McKie S., Deakin J.F., Elliott R. The effect of acute citalopram on face emotion processing in remitted depression: a pharmacoMRI study. Eur Neuropsychopharmacol 2011, 21:140-148.
3. Andin J., Hallbeck M., Mohammed A.H., Marcusson J. Influence of environmental enrichment on steady-state mRNA levels for EAAC1, AMPA1 and NMDA2A receptor subunits in rat hippocampus. Brain Res 2007, 1174:18-27.
4. Arango V., Ernsberger P., Marzuk P.M., Chen J.S., Tierney H., Stanley M., Reis D.J., Mann J.J. Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 1990, 47:1038-1047.
5. Arora R.C., Meltzer H.Y. Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. Am J Psychiatry 1989, 146:730-736.
6. Arranz B., Eriksson A., Mellerup E., Plenge P., Marcusson J. Brain 5-HT1A, 5-HT1D, and 5-HT2 receptors in suicide victims. Biol Psychiatry 1994, 35:457-463.
7. Baca E., Garcia-Garcia M., Porras-Chavarino A. Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:57-65.
8. Baker S., Bielajew C. Influence of housing on the consequences of chronic mild stress in female rats. Stress 2007, 10:283-293.
9. Bambico F.R., Nguyen N.T., Gobbi G. Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress. Eur Neuropsychopharmacol 2009, 19:215-228.
10. 2C receptor mRNA expression in Rat prefrontal/frontal cortex and hippocampus. Neuropsychobiology 2011, 63:160-168.
11. Becker J.B., Arnold A.P., Berkley K.J., Blaustein J.D., Eckel L.A., Hampson E., Herman J.P., Marts S., Sadee W., Steiner M., Taylor J., Young E. Strategies and methods for research on sex differences in brain and behavior. Endocrinology 2005, 146:1650-1673.
12. Bekris S., Antoniou K., Daskas S., Papadopoulou-Daifoti Z. Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains. Behav Brain Res 2005, 161:45-59.
13. Biegon A., McEwen B.S. Modulation by estradiol of serotonin receptors in brain. J Neurosci 1982, 2:199-205.
14. Bielajew C., Konkle A.T., Merali Z. The effects of chronic mild stress on male Sprague-Dawley and Long Evans rats: I. Biochemical and physiological analyses. Behav Brain Res 2002, 136:583-592.
15. Canton H., Emeson R.B., Barker E.L., Backstrom J.R., Lu J.T., Chang M.S., Sanders-Bush E. Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing. Mol Pharmacol 1996, 50:799-807.
16. Carballedo A., Scheuerecker J., Meisenzahl E., Schoepf V., Bokde A., Moller H.J., Doyle M., Wiesmann M., Frodl T. Functional connectivity of emotional processing in depression. J Affect Disord 2011, 134:272-279.
17. Carpenter L.L., Yasmin S., Price L.H. A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine. Biol Psychiatry 2002, 51:183-188.
18. Carrasco G.A., Van de Kar L.D. Neuroendocrine pharmacology of stress. Eur J Pharmacol 2003, 463:235-272.
19. Celada P., Puig M., Amargós-Bosch M., Adell A., Artigas F. The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci 2004, 29:252-265.
20. Cerqueira J.J., Mailliet F., Almeida O.F., Jay T.M., Sousa N. The prefrontal cortex as a key target of the maladaptive response to stress. J Neurosci 2007, 27:2781-2787.
21. Clarke S.N., Ossenkopp K.P. Taste reactivity responses in rats: influence of sex and the estrous cycle. Am J Physiol 1998, 274:718-724.
22. Dalla C., Antoniou K., Drossopoulou G., Xagoraris M., Kokras N., Sfikakis A., Papadopoulou-Daifoti Z. Chronic mild stress impact: are females more vulnerable?. Neuroscience 2005, 135:703-714.
23. Dalla C., Antoniou K., Kokras N., Drossopoulou G., Papathanasiou G., Bekris S., Daskas S., Papadopoulou-Daifoti Z. Sex differences in the effects of two stress paradigms on dopaminergic neurotransmission. Physiol Behav 2008, 93:595-605.
24. Dalla C., Pitychoutis P.M., Kokras N., Papadopoulou-Daifoti Z. Sex differences in animal models of depression and antidepressant response. Basic Clin Pharmacol Toxicol 2010, 106:226-233.
25. Dalla C., Pitychoutis P.M., Kokras N., Papadopoulou-Daifoti Z. Sex differences in response to stress and expression of depressive-like behaviours in the rat. Curr Top Behav Neurosci 2011, 8:97-118.
26. Drevets W.C. Orbitofrontal cortex function and structure in depression. Ann N Y Acad Sci 2007, 1121:499-527.
27. Drevets W.C., Frank E., Price J.C., Kupfer D.J., Holt D., Greer P.J., Huang Y., Gautier C., Mathis C. PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 1999, 46:1375-1387.
28. Drossopoulou G., Antoniou K., Kitraki E., Papathanasiou G., Papalexi E., Dalla C., Papadopoulou-Daifoti Z. Sex differences in behavioral, neurochemical and neuroendocrine effects induced by the forced swim test in rats. Neuroscience 2004, 126:849-857.
29. Duman R.S. Novel therapeutic approaches beyond the serotonin receptor. Biol Psychiatry 1998, 44:324-335.
30. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997, 54:597-606.
31. Duncko R., Kiss A., Skultétyová I., Rusnak M., Jezova D. Corticotropin-releasing hormone mRNA levels in response to chronic mild stress rise in male but not in female rats while tyrosine hydroxylase mRNA levels decrease in both sexes. Psychoneuroendocrinology 2001, 26:77-89.
32. Dwivedi Y., Mondal A.C., Payappagoudar G.V., Rizavi H.S. Differential regulation of serotonin (5HT)(2A) receptor mRNA and protein levels after single and repeated stress in rat brain: role in learned helplessness behavior. Neuropharmacology 2005, 48:204-214.
33. Elakovića I., Djordjevic A., Adzicb M., Djordjevicb J., Radojčićb M., Matića M. Gender-specific response of brain corticosteroid receptors to stress and fluoxetine. Brain Res 2011, 1384:61-68.
34. Filipek P.A., Richelme C., Kennedy D.N., Caviness V.S. The young adult human brain: an MRI-based morphometric analysis. Cereb Cortex 1994, 4:344-360.
35. Fischette C.T., Biegon A., McEwen B.S. Sex differences in serotonin 1 receptor binding in rat brain. Science 1983, 222:333-335.
36. Frankfurt M., McKittrick C.R., Mendelson S.D., McEwen B.S. Effect of 5,7-dihydroxytryptamine, ovariectomy and gonadal steroids on serotonin receptor binding in rat brain. Neuroendocrinology 1994, 59:245-250.
37. Frazer A., Hensler J.G. 5-HT1A receptors and 5-HT1A-mediated responses: effect of treatments that modify serotonergic neurotransmission. Ann N Y Acad Sci 1990, 600:460-474.
38. Galea L.A., McEwen B.S., Tanapat P., Deak T., Spencer R.L., Dhabhar F.S. Sex differences in dendritic atrophy of CA3 pyramidal neurons in response to chronic restraint stress. Neuroscience 1997, 81:689-697.
39. Greenspan J.D., Craft R.M., LeResche L., Arendt-Nielsen L., Berkley K.J., Fillingim R.B., Gold M.S., Holdcroft A., Lautenbacher S., Mayer E.A., Mogil J.S., Murphy A.Z., Traub R.J. Studying sex and gender differences in pain and analgesia: a consensus report. Pain 2007, 132(Suppl 1):S26-S45.
40. Grigoriadis S., Robinson G.E. Gender issues in depression. Ann Clin Psychiatry 2007, 19:247-255.
41. Grippo A.J., Francis J., Beltz T.G., Felder R.B., Johnson A.K. Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia. Physiol Behav 2005, 84:697-706.
42. Grippo A.J., Sullivan N.R., Damjanoska K.J., Crane J.W., Carrasco G.A., Shi J., Chen Z., Garcia F., Muma N.A., Van de Kar L.D. Chronic mild stress induces behavioral and physiological changes, and may alter serotonin 1A receptor function, in male and cycling female rats. Psychopharmacol (Berl) 2005, 179:769-780.
43. Groenewegen H.J., Uylings H.B. The prefrontal cortex and the integration of sensory, limbic and autonomic information. Prog Brain Res 2000, 126:3-28.
44. Grønli J., Murison R., Bjorvatn B., Sorensen E., Portas C.M., Ursin R. Chronic mild stress affects sucrose intake and sleep in rats. Behav Brain Res 2004, 150:139-147.
45. Hanley N.R., Van de Kar L.D. Serotonin and the neuroendocrine regulation of the hypothalamic-pituitary-adrenal axis in health and disease. Vitam Horm 2003, 66:189-255.
46. Harasty J., Double K.L., Halliday G.M., Kril J.J., McRitchie D.A. Language-associated cortical regions are proportionally larger in the female brain. Arch Neurol 1997, 54:171-176.
47. Hildebrandt M.G., Steyerberg E.W., Stage K.B., Passchier J., Kragh-Soerensen P. Are gender differences important for the clinical effects of antidepressants?. Am J Psychiatry 2003, 160:1643-1650.
48. Holden C. Sex and the suffering brain. Science 2005, 308:1574.
49. Hoyer D., Hannon J.P., Martin G.R. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 2002, 71:533-554.
50. Hrdina P.D., Du L. Levels of serotonin receptor 2A higher in suicide victims?. Am J Psychiatry 2001, 158:147-148.
51. Iwamoto K., Bundo M., Kato T. Serotonin receptor 2C and mental disorders: genetic, expression and RNA editing studies. RNA Biol 2009, 6:248-253.
52. Jans L.A., Riedel W.J., Markus C.R., Blokland A. Serotonergic vulnerability and depression: assumptions, experimental evidence and implications. Mol Psychiatry 2007, 12:522-543.
53. 2C receptor ligands. ScientificWorldJournal 2010, 10:1870-1885.
54. Joëls M., Verkuyl J.M., Van Riel E. Hippocampal and hypothalamic function after chronic stress. Ann N Y Acad Sci 2003, 1007:367-378.
55. Kamper E.F., Chatzigeorgiou A., Tsimpoukidi O., Kamper M., Dalla C., Pitychoutis P.M., Papadopoulou-Daifoti Z. Sex differences in oxidant/antioxidant balance under a chronic mild stress regime. Physiol Behav 2009, 98:215-222.
56. 2C receptors in forebrain leads to elevated anxiety and hypoactivity. Eur J Neurosci 2009, 30:299-306.
57. Kimura M., Sudhir K., Jones M., Simpson E., Jefferis A.M., Chin-Dusting J.P. Impaired acetylcholine-induced release of nitric oxide in the aorta of male aromatase-knockout mice: regulation of nitric oxide production by endogenous sex hormones in males. Circ Res 2003, 93:1267-1271.
58. Kokras N., Antoniou K., Dalla C., Bekris S., Xagoraris M., Ovestreet D.H., Papadopoulou-Daifoti Z. Sex-related differential response to clomipramine treatment in a rat model of depression. J Psychopharmacol 2009, 23:945-956.
59. Kokras N., Dalla C., Sideris A.C., Dendi A., Mikail H.G., Antoniou K., Papadopoulou-Daifoti Z. Behavioral sexual dimorphism in models of anxiety and depression due to changes in HPA axis activity. Neuropharmacology 2012, 62:436-445.
60. Lanfumey L., Mongeau R., Cohen-Salmon C., Hamon M. Corticosteroid-serotonin interactions in the neurobiological mechanisms of stress-related disorders. Neurosci Biobehav Rev 2008, 32:1174-1184.
61. Liu C.Q., Shan L., Balesar R., Luchetti S., Van Heerikhuize J.J., Luo J.H., Swaab D.F. A quantitative in situ hybridization protocol for formalin-fixed paraffin-embedded archival post-mortem human brain tissue. Methods 2010, 52:359-366.
62. López J.F., Chalmers D.T., Little K.Y., Watson S.J. AE Bennett research award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol Psychiatry 1998, 43:547-573.
63. López J.F., Vázquez D.M., Chalmers D.T., Watson S.J. Regulation of 5-HT receptors and the hypothalamic-pituitary-adrenal axis. Implications for the neurobiology of suicide. Ann N Y Acad Sci 1997, 836:106-134.
64. López-Figueroa A.L., Norton C.S., López-Figueroa M.O., Armellini-Dodel D., Burke S., Akil H., Lopez J.F., Watson S.J. Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia. Biol Psychiatry 2004, 55:225-233.
65. Marangell L.B., Johnson C.R., Kertz B., Zboyan H.A., Martinez J.M. Olanzapine in the treatment of apathy in previously depressed participants maintained with selective serotonin reuptake inhibitors: an open-label, flexible-dose study. J Clin Psychiatry 2002, 63:391-395.
66. Marcus S.M., Kerber K.B., Rush A.J., Wisniewski S.R., Nierenberg A., Balasubramani G.K., Ritz L., Kornstein S., Young E.A., Trivedi M.H. Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the sequenced treatment alternatives to relieve depression study. Compr Psychiatry 2008, 49:238-246.
67. Marcus S.M., Young E.A., Kerber K.B., Kornstein S., Farabaugh A.H., Mitchell J., Wisniewski S.R., Balasubramani G.K., Trivedi M.H., Rush A.J. Gender differences in depression: findings from the STAR*D study. J Affect Disord 2005, 87:141-150.
68. Mayberg H.S. Limbic-cortical dysregulation: a proposed model of depression. J Neuropsychiatry Clin Neurosci 1997, 9:471-481.
69. McKittrick C.R., Blanchard D.C., Blanchard R.J., McEwen B.S., Sakai R.R. Serotonin receptor binding in a colony model of chronic social stress. Biol Psychiatry 1995, 37:383-393.
70. Mendelson S.D., McEwen B.S. Autoradiographic analyses of the effects of restraint-induced stress on 5-HT1A, 5-HT1C and 5-HT2 receptors in the dorsal hippocampus of male and female rats. Neuroendocrinology 1991, 54:454-461.
71. Moses-Kolko E.L., Price J.C., Thase M.E., Meltzer C.C., Kupfer D.J., Mathis C.A., Bogers W.D., Berman S.R., Houck P.R., Schneider T.N., Drevets W.C. Measurement of 5-HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY-100635. Synapse 2007, 61:523-530.
72. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron 2002, 34:13-25.
73. Newman M.E., Gur E., Dremencov E., Garcia F., Lerer B., Van de Kar L.D. Chronic clomipramine alters presynaptic 5-HT(1B) and postsynaptic 5-HT(1A) receptor sensitivity in rat hypothalamus and hippocampus, respectively. Neuropharmacology 2000, 39:2309-2317.
74. Ostroff R.B., Nelson J.C. Risperidone augmentation of selective serotonin reuptake inhibitors in major depression. J Clin Psychiatry 1999, 60:256-259.
75. Pallotta M., Segieth J., Whitton P.S. Chronic but not acute clomipramine alters the effect of NMDA receptor regulation of dopamine release in rat frontal cortex. Neurosci Lett 1999, 262:187-190.
76. Pandey G.N., Dwivedi Y., Rizavi H.S., Ren X., Pandey S.C., Pesold C., Roberts R.C., Conley R.R., Tamminga C.A. Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry 2002, 159:419-429.
77. Papp M., Klimek V., Willner P. Effects of imipramine on serotonergic and beta-adrenergic receptor binding in a realistic animal model of depression. Psychopharmacol (Berl) 1994, 114:309-314.
78. Parsey R.V., Oquendo M.A., Simpson N.R., Ogden R.T., Van Heertum R., Arango V., Mann J.J. Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635. Brain Res 2002, 954:173-182.
79. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1986, Academic Press, San Diego, CA. 2nd edition.
80. Pehek E.A., Nocjar C., Roth B.L., Byrd T.A., Mabrouk O.S. Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex. Neuropsychopharmacology 2006, 31:265-277.
81. Pittenger C., Duman R.S. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008, 33:88-109.
82. Pitychoutis P.M., Griva E., Ioannou K., Tsitsilonis O.E., Papadopoulou-Daifoti Z. Chronic antidepressant treatment exerts sexually dimorphic immunomodulatory effects in an experimental model of major depression: do females lack an advantage?. Int J Neuropsychopharmacol 2009, 12:1157-1163.
83. Pitychoutis P.M., Nakamura K., Tsonis P.A., Papadopoulou-Daifoti Z. Neurochemical and behavioral alterations in an inflammatory model of depression: sex differences exposed. Neuroscience 2009, 159:1216-1232.
84. Pitychoutis P.M., Pallis E.G., Mikail H.G., Papadopoulou-Daifoti Z. Individual differences in novelty-seeking predict differential responses to chronic antidepressant treatment through sex- and phenotype-dependent neurochemical signatures. Behav Brain Res 2011, 223:154-168.
85. Pitychoutis P.M., Papadopoulou-Daifoti Z. Of depression and immunity: does sex matter?. Int J Neuropsychopharmacol 2010, 13:675-689.
86. Pitychoutis P.M., Tsitsilonis O.E., Papadopoulou-Daifoti Z. Antidepressant pharmacotherapy: focus on sex differences in neuroimmunopharmacological crossroads. Future Neurology 2010, 5:581-596.
87. Pitychoutis P.M., Zisaki A., Dalla C., Papadopoulou-Daifoti Z. Pharmacogenetic insights into depression and antidepressant response: does sex matter?. Curr Pharm Des 2010, 16:2214-2223.
88. Pritchett D.B., Bach A.W., Wozny M., Taleb O., Dal Toso R., Shih J.C., Seeburg P.H. Structure and functional expression of cloned rat serotonin 5HT-2 receptor. EMBO J 1988, 7:4135-4140.
89. Roberts A.C. The importance of serotonin for orbitofrontal function. Biol Psychiatry 2011, 69:1185-1191.
90. Rocher C., Spedding M., Munoz C., Jay T.M. Acute stress-induced changes in hippocampal/prefrontal circuits in rats: effects of antidepressants. Cereb Cortex 2004, 14:224-229.
91. Sargent P.A., Kjaer K.H., Bench C.J., Rabiner E.A., Messa C., Meyer J., Gunn R.N., Grasby P.M., Cowen P.J. Brain serotonin1 A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry 2000, 57:174-180.
92. Savitz J., Lucki I., Drevets W.C. 5-HT(1A) receptor function in major depressive disorder. Prog Neurobiol 2009, 88:17-31.
93. Schiller L., Jähkel M., Kretzschmar M., Brust P., Oehler J. Autoradiographic analyses of 5-HT1A and 5-HT2A receptors after social isolation in mice. Brain Res 2003, 980:169-178.
94. Seale J.V., Wood S.A., Atkinson H.C., Bate E., Lightman S.L., Ingram C.D., Jessop D.S., Harbuz M.S. Gonadectomy reverses the sexually diergic patterns of circadian and stress-induced hypothalamic-pituitary-adrenal axis activity in male and female rats. J Neuroendocrinol 2004, 16:516-524.
95. Sfikakis A., Pitychoutis P.M., Antoniou K., Bikas N., Papadopoulou-Daifoti Z. The impact of the hormonal milieu and stress-associated hypothalamic dopaminergic activation on the rapid compensatory adrenal growth in cycling female rats. Hormones (Athens) 2008, 7:303-312.
96. Shelton R.C., Tollefson G.D., Tohen M., Stahl S., Gannon K.S., Jacobs T.G., Buras W.R., Bymaster F.P., Zhang W., Spencer K.A., Feldman P.D., Meltzer H.Y. A novel augmentation strategy for treating resistant major depression. Am J Psychiatry 2001, 158:131-134.
97. Silberman D.M., Wald M., Genaro A.M. Effects of chronic mild stress on lymphocyte proliferative response. Participation of serum thyroid hormones and corticosterone. Int Immunopharmacol 2002, 2:487-497.
98. Sloan D.M., Kornstein S.G. Gender differences in depression and response to antidepressant treatment. Psychiatr Clin North Am 2003, 26:581-594.
99. Small S.A., Schobel S.A., Buxton R.B., Witter M.P., Barnes C.A. A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat Rev Neurosci 2011, 12:585-601.
100. 2C receptors. Neuropharmacology 2011, 61:489-494.
101. Srinivas B.N., Subhash M.N., Vinod K.Y. Cortical 5-HT(1A) receptor downregulation by antidepressants in rat brain. Neurochem Int 2001, 38:573-579.
102. Stamatakis A., Mantelas A., Papaioannou A., Pondiki S., Fameli M., Stylianopoulou F. Effect of neonatal handling on serotonin 1A sub-type receptors in the rat hippocampus. Neuroscience 2006, 140:1-11.
103. Stockmeier C.A. Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J Psychiatr Res 2003, 37:357-373.
104. Stockmeier C.A., Howley E., Shi X., Sobanska A., Clarke G., Friedman L., Rajkowska G. Antagonist but not agonist labeling of serotonin-1A receptors is decreased in major depressive disorder. J Psychiatr Res 2009, 43:887-894.
105. Subhash M.N., Jagadeesh S. Imipramine-induced changes in 5-HT2 receptor sites and inositoltrisphosphate levels in rat brain. Neurochem Res 1997, 22:1095-1099.
106. Trajkovska V., Kirkegaard L., Krey G., Marcussen A.B., Thomsen M.S., Chourbaji S., Brandwein C., Ridder S., Halldin C., Gass P., Knudsen G.M., Aznar S. Activation of glucocorticoid receptors increases 5-HT2A receptor levels. Exp Neurol 2009, 218:83-91.
107. Treadway M.T., Zald D.H. Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev 2011, 35:537-555.
108. Turecki G., Brière R., Dewar K., Antonetti T., Lesage A.D., Seguin M., Chawky N., Vanier C., Alda M., Joober R., Benkelfat C., Rouleau G.A. Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. Am J Psychiatry 1999, 156:1456-1468.
109. Van de Kar L.D., Blair M.L. Forebrain pathways mediating stress-induced hormone secretion. Front Neuroendocrinol 1999, 20(1):1-48.
110. Van Riel E., Meijer O.C., Steenbergen P.J., Joëls M. Chronic unpredictable stress causes attenuation of serotonin responses in cornu ammonis 1 pyramidal neurons. Neuroscience 2003, 120:649-658.
111. Vázquez-Borsetti P., Cortés R., Artigas F. Pyramidal neurons in rat prefrontal cortex projecting to ventral tegmental area and dorsal raphe nucleus express 5-HT2A receptors. Cereb Cortex 2009, 19:1678-1686.
112. Wang H.T., Han F., Shi Y.X. Activity of the 5-HT1A receptor is involved in the alteration of glucocorticoid receptor in hippocampus and corticotropin-releasing factor in hypothalamus in SPS rats. Int J Mol Med 2009, 24:227-231.
113. Watanabe Y., Sakai R.R., McEwen B.S., Mendelson S. Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin. Brain Res 1993, 615:87-94.
114. Welborn B.L., Papademetris X., Reis D.L., Rajeevan N., Bloise S.M., Gray J.R. Variation in orbitofrontal cortex volume: relation to sex, emotion regulation and affect. Soc Cogn Affect Neurosci 2009, 4:328-339.
115. Welner S.A., De Montigny C., Desroches J., Desjardins P., Suranyi-Cadotte B.E. Autoradiographic quantification of serotonin1A receptors in rat brain following antidepressant drug treatment. Synapse 1989, 4:347-352.
116. Whitaker-Azmitia P.M., Druse M., Walker P., Lauder J.M. Serotonin as a developmental signal. Behav Brain Res 1996, 73:19-29.
117. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacol (Berl) 1997, 134:319-329.
118. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005, 52:90-110.
119. Willner P., Towell A., Sampson D., Sophokleous S., Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacol (Berl) 1987, 93:358-364.
120. Young E.A., Kornstein S.G., Marcus S.M., Harvey A.T., Warden D., Wisniewski S.R., Balasubramani G.K., Fava M., Trivedi M.H., John Rush A. Sex differences in response to citalopram: a STAR*D report. J Psychiatr Res 2009, 43:503-511.
121. Zhang L., Ma W., Barker J.L., Rubinow D.R. Sex differences in expression of serotonin receptors (subtypes 1A and 2A) in rat brain: a possible role of testosterone. Neuroscience 1999, 94:251-259.
122. Zucker I. Hormonal determinants of sex differences in saccharin preference, food intake and body weight. Physiol Behav 1969, 4:595-602.